{reportSlug=global-next-generation-cancer-diagnostic-market, reportId=163703, mktKeyword=Next Generation Cancer Diagnostic, cagr=0.00, publishDate=Apr 2024, priceOption2=7500, reportTitle=Next Generation Cancer Diagnostic Comprehensive Study by Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), Function (Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), Technology (Next Generation Sequencing, QPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), End User (Academic Institutes & Research Centres, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=216, priceOption1=3750, forecastYr=2030, noOfPages=217, reportKey=163215, breadcrum=Global Next Generation Cancer Diagnostic Market}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Apr 2024 217 Pages 73 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales